Rua Bioscience Limited — Share Issue/Capital Change 2024

Jun 4, 2024

Capital Change Notice

Updated as at June 2023

==> picture [101 x 49] intentionally omitted <==

	Section 1: Issuer information
	Name of issuer	Rua Bioscience Limited
	NZX ticker code	RUA
	Class of financial product	Ordinary Shares
	ISIN (If unknown, check on NZX website)	NZRUAE0004S1
	Currency	$NZ
	Section 2: Capital change details
	Number issued/acquired/redeemed	1,614,314
	Nominal value (if any)	n/a
	Issue/acquisition/redemption price per security	$nil
	Nature of the payment (for example, cash or other consideration)	Zero– provision of employment and personal services to the Issuer.
	Amount paid up (if not in full)	Fully paid
	Percentage of total class of Financial Products issued/acquired/redeemed/ (calculated on the number of Financial Products of the Class, excluding any Treasury Stock, in existence)1	1.02%
	For an issue of Convertible Financial Products or Options, the principal terms of Conversion (for example the Conversion price and Conversion date and the ranking of the Financial Product in relation to other Classes of Financial Product) or the Option (for example, the exercise price and exercise date)	The ordinary shares have been issued upon the conversion of Options granted on 1 June 2023 in a ratio of 1:1, for NIL cash consideration, subject to conditions set out in Option Deeds for each Participant dated May 2023
	Option (for
	Reason for	The ordinary shares have been issued upon the conversion of Options which were granted on 1 June 2023 in a ratio of 1:1, for NIL cash consideration (consideration provided was services and performance incentive for employees (part of remuneration package)), subject to conditions set out in Option Deeds for each Participant dated May 2023
	Total number of Financial Products of the Class after the issue/acquisition/redemption/Conversion (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue/acquisition/redemption.	159,750,579

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

==> picture [101 x 49] intentionally omitted <==

Capital Change Notice

Updated as at June 2023

In the case of an acquisition of shares, whether those shares are to be held as treasury stock	n/a
Specific authority for the issue, acquisition, or redemption, including a reference to the rule pursuant to which the issue, acquisition, or redemption is made	Listing rules 4.6.1 and 4.11.1 and Board resolution under which the terms of issue of the Options were approved
Terms or details of theissue,acquisition, or redemption (for example: restrictions, escrow arrangements)	Vesting and conversion into ordinary shares of Options that were granted to certain employees on 1 June 2023 in accordance with conditions set out in Option Deeds for each Participant dated May 2023. Of the 2,100,000 Options granted on 1 June 2023, 485,686 have lapsed in accordance with the terms of issue. This Notice therefore relates to the ordinary shares that have been issued upon the vesting of the balance of the Options that were granted.
Date of issue/acquisition/redemption2	04/06/2024
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Paul Naske
Contact person for this announcement	Paul Naske
Contact phone number	021445154
Contact email address	Paul.naske@ruabio.com
Date of release through MAP	04/06/2024

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).